North America Aesthetic & Cosmetic Surgery Devices Market, By Type (Breast Implant/Mammary Implants, Implants for the Body and Custom Made Implants), Raw Material (Polymers, Metals, and Biomaterials), End User (Clinics, Hospitals, Dermatology Clinics and others), Distribution Channel (Direct Tender, Retail Pharmacies), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028.
Market Analysis and Insights: North America Aesthetic and Cosmetic Surgery Devices Market
Aesthetic & cosmetic surgery devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.0% in the forecast period of 2021 to 2028 and is expected to reach USD 1,985.42 million by 2028. Increasing usage of aesthetic & cosmetic surgery devices’ products, growing geriatric populace are the major drivers which propelled the demand of the market in the forecast period.
Advancement in healthcare infrastructure effectively help the growth of the aesthetic & cosmetic surgery devices market. However, the complications associated with the aesthetic & cosmetic surgery devices may hamper the future growth of aesthetic & cosmetic surgery devices market. The partnerships and acquisitions by major market players act as opportunity for the growth of aesthetic & cosmetic surgery devices market.
Aesthetic & cosmetic surgery devices market is growing tremendously across the globe due to the growing geriatric population across globe. The presence of wide range of aesthetic & cosmetic surgery devices products is satisfying the need of the surgeons during aesthetic & cosmetic surgery. The increased technological advancement leads to increased product launch by key market players of the aesthetic & cosmetic surgery devices market. Major factors driving the growth of this market are rising per capita income, technological advancement and growing awareness about reconstructive breast surgeries among other and the factor which hampers the growth of this market are escalating product recall and high cost of treatment among more.
The aesthetic & cosmetic surgery devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
North America Aesthetic & Cosmetic Surgery Devices Market Scope and Market Size
Aesthetic & cosmetic surgery devices market is segmented on the basis of type, raw material, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the aesthetic & cosmetic surgery devices market is segmented into breast implant/mammary implants, implants for the body and custom made implants. In 2021, breast implant/mammary implants are dominating the market due to the rising prevalence & incidence of breast cancer across the globe.
- On the basis of raw material, the aesthetic & cosmetic surgery devices market is segmented into polymers, metals, and biomaterials. In 2021, polymers are dominating the market due to the rising healthcare expenditure and increasing demand of various polymer aesthetic & cosmetic surgery devices.
- On the basis of end user, the aesthetic & cosmetic surgery devices market is segmented into clinics, hospitals, dermatology clinics and others. In 2021, hospitals segment is dominating the market as it provides patients with best and accessible healthcare services.
- On the basis of distribution channel, the aesthetic & cosmetic surgery devices market is segmented into direct tender and retail pharmacies. In 2021, direct tender segment is dominating the market because direct tender holds the largest market share along with highest CAGR because most of the service providers buy the devices from manufacturers, and it is noticed that revenue from direct sales is higher; so it is influential as well as growing in the market.
Aesthetic & Cosmetic Surgery Devices Market Country Level Analysis
The aesthetic & cosmetic surgery devices market is analysed and market size information is provided by type, raw material, end user and distribution channel referenced above.
The countries covered in the North America aesthetic & cosmetic surgery devices market report are the U.S., Canada, and Mexico.
North America is expected to dominate the market due to the high adoption of aesthetic & cosmetic surgery devices by the patients in the region. The U.S is dominating in the market and leading the growth in the North America market due to increased presence of key market players in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Acquisition and Merger in Aesthetic & Cosmetic Surgery Devices Market is Creating New Opportunities for Players
Aesthetic & cosmetic surgery devices market also provides you with detailed market analysis for every country growth. Additionally, it provides data regarding acquisition and agreement among the major market plyers and start-up companies. Moreover, growing impact of research and development activities on aesthetic & cosmetic surgery devices market growth pace. The data is available for historic period 2010 to 2019.
Competitive Landscape and Aesthetic & Cosmetic Surgery Devices Market Share Analysis
Aesthetic & cosmetic surgery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to aesthetic & cosmetic surgery devices market.
The major players covered in the report Johnson & Johnson Services, Inc., Allergan (A Subsidiary of abbvie INC.), Airxpanders, Inc., Bonashmedical, Cereplas, Coloplast Corp, DPS Technology Development Ltd, Establishment Labs S.A., GC Aesthetics, Hansbiomed co. Ltd, Ideal Implant Incorporated, Implantech, Koken Co., Ltd., Laboratoires Arion, PMT Corporation, Polytech Health & Aesthetics Gmbh, Rigicon Inc., Sebbin, Shanghai Kangning Medical Supplies Ltd., Sientra, Inc., Silimed, Stryker, Surgisil LLP, Wanhe, Xilloc Medical B.V., Integra Lifesciences, Lipoelastic A.S., Defygravity, and Karl Storz Se & Co. Kg among others domestic and North America players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Growing contract, partnership and acquisition by key players accelerating the aesthetic & cosmetic surgery devices market growth.
For instance,
- In May 2020, AbbVie Inc. has completed its acquisition of Allergan. This acquisition has helped AbbVie Inc. to increase its market and demand for its product in future as the acquisition has combined the product portfolio of the companies thereby strengthening their business.
- In June 2019, Establishment Labs S.A. collaborated with the Ipomia, a firm which is engaged in manufacturing to create a line of bras, that is, post-op bras exclusively for women who receive breast surgery with Motiva Implants. This new collaboration has increased the credibility of the company in the market.
Collaboration, joint ventures and other strategies by the market player is enhancing the company footprints in the aesthetic & cosmetic surgery devices market which also provides the benefit for organisation growth pace.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA BREAST RECONSTRUCTION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 MARKET END USER COVERAGE GRID
4 PREMIUM INSIGHT
5 BREAST IMPLANTS FROM BREAST CANCER CASES (2020)
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE & INCIDENCE OF BREAST CANCER
6.1.2 INCREASING AESTHETIC APPEARANCE
6.1.3 GROWING AWARENESS ABOUT RECONSTRUCTIVE BREAST SURGERIES
6.1.4 INCREASING TECHNOLOGY ADVANTAGES IN BREAST RECONSTRUCTIVE PROCEDURES
6.2 RESTRAINTS
6.2.1 PRODUCT RECALL
6.2.2 HIGH COST OF TREATMENT
6.3 OPPORTUNITIES
6.3.1 INNOVATION AND ADVANCEMENT
6.3.2 INCREASING MEDICAL TOURISM
6.4 CHALLENGE
6.4.1 POST-SURGERY COMPLICATION
6.4.2 EMERGENCE OF COVID-19
7 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE
7.1 OVERVIEW
7.2 BREAST IMPLANTS
7.2.1 SILICONE
7.2.2 SALINE
7.3 TISSUE EXPANDERS
7.4 IMPLANTS ACCESSORIES
8 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 INFRAMAMMARY
8.3 TRANS-AXILLARY
8.4 PERI-AREOLAR
8.5 TRANSUMBILICAL
9 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE
9.1 OVERVIEW
9.2 ROUND IMPLANT SHAPE
9.3 ANATOMICAL IMPLANT SHAPE
9.4 ROUND EXPANDER SHAPE
9.5 ANATOMICAL EXPANDER SHAPE
10 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY PLACEMENT
10.1 OVERVIEW
10.2 DUAL-PLANE INSERTION
10.3 SUBGLANDULAR INSERTION
10.4 SUBMUSCULAR INSERTION
11 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.3 CLINICS
11.4 AMBULATORY SURGICAL CENTERS
12 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL
13 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY GEOGRAPHY
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA BREAST RECONSTRUCTION MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 COMPANY PROFILE
15.1 JOHNSON & JOHNSON SERVICES, INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 ALLERGAN (A SUBSIDIARY OF ABBVIE INC.)
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 GC AESTHETICS
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 ESTABLISHMENT LABS S.A.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 INTEGRA LIFESCIENCES
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 AIRXPANDERS, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 CEREPLAS
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 DEFYGRAVITY
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 DPS TECHNOLOGY DEVELOPMENT LTD
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 HANSBIOMED CO. LTD
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 IDEAL IMPLANT INCORPORATED
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 KOKEN CO.,LTD.
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 KARL STORZ SE & CO. KG
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 LABORATOIRES ARION
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 LIPOELASTIC A.S.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 PMT CORPORATION
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 POLYTECH HEALTH & AESTHETICS GMBH
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 SEBBIN
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 SHANGHAI KANGNING MEDICAL SUPPLIES LTD.
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 SIENTRA, INC.
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 WANHE
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 BREAST CANCER RATE IN WORLD IN 2018
TABLE 2 BREAST CANCER RATE IN NORTH AMERICA IN 2018
TABLE 3 NEW CASES OF BREAST CANCER BY AGE GROUP IN AMERICA, 2017
TABLE 4 AESTHETIC BREAST SURGERY PROCEDURE IN AMERICA
TABLE 5 AESTHETIC BREAST SURGERY PROCEDURE IN SOME COUNTRIES OF LATIN AMERICA IN THE YEAR 2019
TABLE 6 APPROXIMATE COST OF BREAST AUGMENTATION VARIATIONS IN SAO PAULO, BRAZIL
TABLE 7 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 8 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 9 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 10 NORTH AMERICA TISSUE EXPANDERS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 11 NORTH AMERICA IMPLANTS ACCESSORIES IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 12 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)
TABLE 13 NORTH AMERICA INFRAMAMMARY IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 14 NORTH AMERICA TRANS-AXILLARY IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 15 NORTH AMERICA PERI-AREOLAR IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 16 NORTH AMERICA TRANS UMBILLICAL IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 17 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)
TABLE 18 NORTH AMERICA ROUND IMPLANT SHAPE IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 19 NORTH AMERICA ANATOMICAL IMPLANT SHAPE IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 20 NORTH AMERICA ROUND EXPANDER SHAPE IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ANATOMICAL EXPANDER SHAPE IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 22 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)
TABLE 23 NORTH AMERICA DUAL-PLANE INSERTION IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 24 NORTH AMERICA SUBGLANDULAR INSERTION IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 25 NORTH AMERICA SUBMUSCULAR INSERTION IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 26 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)
TABLE 27 NORTH AMERICA HOSPITAL IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 28 NORTH AMERICA CLINIC IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 29 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 30 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)
TABLE 31 NORTH AMERICA DIRECT TENDER IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 32 NORTH AMERICA RETAIL SALES IN BREAST RECONSTRUCTION MARKET, BY REGION, 2014-2028 (USD MILLION)
TABLE 33 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2014-2028 (USD MILLION)
TABLE 34 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 35 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)
TABLE 36 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)
TABLE 37 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 38 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)
TABLE 39 NORTH AMERICA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)
TABLE 40 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)
TABLE 41 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)
TABLE 42 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)
TABLE 43 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)
TABLE 44 NORTH AMERICA BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)
TABLE 45 U.S. BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 46 U.S. BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)
TABLE 47 U.S. BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)
TABLE 48 U.S. BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 49 U.S. BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)
TABLE 50 U.S. BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)
TABLE 51 U.S. BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)
TABLE 52 U.S. BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)
TABLE 53 U.S. BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)
TABLE 54 U.S. BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)
TABLE 55 U.S. BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)
TABLE 56 CANADA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 57 CANADA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)
TABLE 58 CANADA BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)
TABLE 59 CANADA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 60 CANADA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)
TABLE 61 CANADA BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)
TABLE 62 CANADA BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)
TABLE 63 CANADA BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)
TABLE 64 CANADA BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)
TABLE 65 CANADA BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)
TABLE 66 CANADA BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)
TABLE 67 MEXICO BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 68 MEXICO BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)
TABLE 69 MEXICO BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)
TABLE 70 MEXICO BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (USD MILLION)
TABLE 71 MEXICO BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (UNITS)
TABLE 72 MEXICO BREAST IMPLANTS IN BREAST RECONSTRUCTION MARKET, BY TYPE, 2014-2028 (ASP)
TABLE 73 MEXICO BREAST RECONSTRUCTION MARKET, BY TECHNOLOGY, 2014-2028 (USD MILLION)
TABLE 74 MEXICO BREAST RECONSTRUCTION MARKET, BY RECONSTRUCTION SHAPE, 2014-2028 (USD MILLION)
TABLE 75 MEXICO BREAST RECONSTRUCTION MARKET, BY PLACEMENT, 2014-2028 (USD MILLION)
TABLE 76 MEXICO BREAST RECONSTRUCTION MARKET, BY END USER, 2014-2028 (USD MILLION)
TABLE 77 MEXICO BREAST RECONSTRUCTION MARKET, BY DISTRIBUTION CHANNEL, 2014-2028 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA BREAST RECONSTRUCTION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA BREAST RECONSTRUCTION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA BREAST RECONSTRUCTION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA BREAST RECONSTRUCTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA BREAST RECONSTRUCTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA BREAST RECONSTRUCTION MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA BREAST RECONSTRUCTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA BREAST RECONSTRUCTION MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 GROWING AWARENESS ABOUT RECONSTRUCTIVE BREAST SURGERIES IS EXPECTED TO DRIVE THE NORTH AMERICA BREAST RECONSTRUCTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 BREAT IMPLANTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BREAST RECONSTRUCTION MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA BREAST RECONSTRUCTION MARKET
FIGURE 14 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE, 2020
FIGURE 15 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE, 2014 TO 2028 (USD MILLION)
FIGURE 16 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 17 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TECHNOLOGY, 2020
FIGURE 19 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TECHNOLOGY, 2014 TO 2028 (USD MILLION)
FIGURE 20 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 21 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 22 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY RECONSTRUCTION SHAPE, 2020
FIGURE 23 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY RECONSTRUCTION SHAPE, 2014 TO 2028 (USD MILLION)
FIGURE 24 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY RECONSTRUCTION SHAPE, CAGR (2021-2028)
FIGURE 25 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY RECONSTRUCTION SHAPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY PLACEMENT, 2020
FIGURE 27 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY PLACEMENT, 2014 TO 2028 (USD MILLION)
FIGURE 28 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY PLACEMENT, CAGR (2021-2028)
FIGURE 29 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY PLACEMENT, LIFELINE CURVE
FIGURE 30 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY END USER, 2020
FIGURE 31 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY END USER, 2014 TO 2028 (USD MILLION)
FIGURE 32 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY END USER, CAGR (2021-2028)
FIGURE 33 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 35 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY DISTRIBUTION CHANNEL, 2014 TO 2028 (USD MILLION)
FIGURE 36 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 37 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA BREAST RECONSTRUCTION MARKET: SNAPSHOT (2020)
FIGURE 39 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY COUNTRY (2020)
FIGURE 40 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 NORTH AMERICA BREAST RECONSTRUCTION MARKET: BY TYPE (2021-2028)
FIGURE 43 NORTH AMERICA BREAST RECONSTRUCTION MARKET: COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
